|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: | |||||
| (Income) loss from discontinued operations | |||||
| Gain on sale of assets and investments | |||||
| Pension settlement charge | |||||
| Impairment and related charges | |||||
| Debt modification costs | |||||
| Gain on loan converted to equity | |||||
| Payment of previously paid-in-kind interest | |||||
| Depreciation and amortization | |||||
| Loss on extinguishment of debt, net | |||||
| Stock-based compensation expense | |||||
| Amortization of upfront incentive consideration | |||||
| Amortization of debt discount and issuance costs | |||||
| Paid-in-kind interest | |||||
| Other | |||||
| (Gain) on sale of assets | |||||
| Deferred income taxes | |||||
| Provision for expected credit losses | |||||
| (Gain) loss on investment fair value adjustment | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts and other receivables | |||||
| Prepaid expenses and other current assets | |||||
| Capitalized implementation costs | |||||
| Upfront incentive consideration | |||||
| Other assets | |||||
| Accrued compensation and related benefits | |||||
| Accounts payable and other accrued liabilities | |||||
| Deferred revenue including upfront solution fees | |||||
| Cash (used in) provided by operating activities | |||||
| Investing Activities | |||||
| Additions to property and equipment | |||||
| Proceeds from sale of assets | |||||
| Other investing activities | |||||
| Proceeds from sale of investments in securities | |||||
| Purchase of investments | |||||
| Acquisitions, net of cash acquired | |||||
| Cash (used in) provided by investing activities | |||||
| Cash used in investing activities | |||||
| Financing Activities | |||||
| Payments on borrowings from lenders | |||||
| Proceeds of borrowings from lenders | |||||
| Payments on borrowings under Securitization Facility | |||||
| Proceeds from borrowings under Securitization Facility | |||||
| Debt prepayment fees and issuance costs | |||||
| Net payment on the settlement of equity-based awards | |||||
| Net Receipts on Behalf under TSA | |||||
| Dividends paid on preferred stock | |||||
| Proceeds from sale of redeemable shares in subsidiary | |||||
| Other financing activities | |||||
| Payment for settlement of exchangeable notes | |||||
| Cash (used in) provided by financing activities | |||||
| Cash Flows from Discontinued Operations | |||||
| Cash (used in) provided by operating activities | |||||
| Cash provided by (used in) investing activities | |||||
| Cash provided by (used in) discontinued operations | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Cash payments for income taxes | |||||
| Cash payments for interest | |||||
| Capitalized interest | |||||
| Non-cash additions to property and equipment | |||||
Loading...